#CureHSV
LightNews LightNews
herpesadvocate.bsky.social
#Herpes #HSV #HerpesAwareness #HerpesAdvocacy #HerpesCure #HerpesResearch #CureHSV #SexualHealth #EndTheStigma #HerpesAwarenessDay
Events Archive -
herpescureadvocacy.com
October 5, 2026 at 10:07 PM
herpesadvocate.bsky.social
Great news from Aicuris! We look forward to seeing their next steps! #Aicuris #Herpes #CureHSV #SilentNoMore

www.aicuris.com/press-releas...
Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients - Aicuris
Aicuris has enrolled the final participant in their Phase 3 clinical trial of pritelivir. The study aimed to demonstrate superior efficacy and safety of priteli
www.aicuris.com
July 27, 2025 at 12:08 AM
herpesadvocate.bsky.social
We are so excited to be here at @stihiv2025.org! Stop by our booth T6 to learn more about our work to advance new therapies for HSV - and win a prize! #Herpes #CureHSV #SilentNoMore
July 28, 2025 at 4:12 PM
herpesadvocate.bsky.social
Join us in urging CSTE to make neonatal herpes a reportable condition. Call or email CSTE leadership today — your voice can help save newborn lives and strengthen public health tracking! #Herpes #CureHSV

herpescureadvocacy.com/2025/09/11/h...
Herpes Cure Advocacy Makes Push for Neonatal Herpes as Reportable Condition
Herpes Cure Advocacy is advocating to make the neonatal herpes infection reportable via a recommendation from the CSTE. In this multiple step process to make a condition reportable, the CSTE STI co…
herpescureadvocacy.com
September 16, 2025 at 3:13 AM
herpesadvocate.bsky.social
New Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk - Check out our Takeaways! #CureHSV #SilentNoMore

herpescureadvocacy.com/2025/05/27/n...
New Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk
Here are our key takeaways from the study “Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study” published in BMJ Open…
herpescureadvocacy.com
May 29, 2025 at 4:09 AM
herpesadvocate.bsky.social
Both genital HSV-2 (I$31·2 billion) and HSV-1 (I$4·0 billion) infections and their consequences were estimated to cost I$35·3 billion globally in 2016.

#HerpesAwareness #CureHSV #Herpes #SilentNoMore
bmcglobalpublichealth.biomedcentral.com/articles/10....
Estimated global and regional economic burden of genital herpes simplex virus infection among 15–49 year-olds in 2016 - BMC Global and Public Health
Background Globally, herpes simplex virus (HSV)-2 and -1 infections contribute to a large disease burden, but their full economic consequences remain unclear. This study aims to estimate the global ec...
bmcglobalpublichealth.biomedcentral.com
November 23, 2024 at 5:04 AM
herpesadvocate.bsky.social
Are you signed up for our newsletter? Each month, we share the latest news, upcoming events, and ways to take action. Don’t miss out—join our mailing list to stay informed and engaged! #herpes #curehsv

herpescureadvocacy.com/members/
Become an Advocate!
Join our nearly 10,000 members rallying for a cure.
herpescureadvocacy.com
September 1, 2025 at 9:33 PM
herpesadvocate.bsky.social
We are looking for impact stories for future marketing content. If you are willing, please let us know:

🔵How have you benefitted from HCA resources (website, events, etc.)?
🔵Why do you donate to HCA? Either time if you're a volunteer or monetary donations?

#herpes #curehsv
August 31, 2025 at 6:18 PM
herpesadvocate.bsky.social
We’re growing our movement and need motivated people to join us! Whether you have experience in fundraising, policy work, or you’re simply passionate about driving change— your skills can help push our efforts forward. #CureHSV Learn more here:

herpescureadvocacy.com/2025/08/20/a...
Applications Open for HCA Board of Directors
Herpes Cure Advocacy Seeks Volunteer Members for Board of Directors Herpes Cure Advocacy (HCA) is issuing a call for individuals to serve on its Board of Directors. We are seeking individuals with …
herpescureadvocacy.com
August 23, 2025 at 8:35 PM
herpesadvocate.bsky.social
Great article from two of our very own board members! Advocacy can come in many forms, this is one such way that sheds light on the issue and raises awareness! #SilentNoMore #CureHSV

www.medpagetoday.com/opinion/seco...
Opinion | Why Hasn't Herpes Treatment Advanced in 40 Years?
We cannot ignore the health consequences and shame faced by people with herpes
www.medpagetoday.com
August 19, 2025 at 12:56 AM
herpesadvocate.bsky.social
Did you know Sunday's are a great time to start your advocacy efforts? Check out our advocates starter guide on ways you can get involved! We all have a voice to use! #SilentNoMore #CureHSV

herpescureadvocacy.com/2021/10/16/n...
New HSV Advocates: A Starters Guide to Activism
Getting started with Herpes Advocacy Step 1: Get Informed GET INFORMED: Make sure you know the Herpes 101 facts so you can speak to them in your advocacy. Read the latest news. Sign up for Herpes C…
herpescureadvocacy.com
August 17, 2025 at 3:28 PM
herpesadvocate.bsky.social
Great article on Dr. David Knipe, a virologist at @harvard.edu who has studied HSV for over four decades. We are so grateful on his continued commitment to studying HSV!

#CureHSV #SilentNoMore #HerpesAdvocate

magazine.hms.harvard.edu/articles/i-a...
“I Am Determined to Carry On This Vital Work”
magazine.hms.harvard.edu
July 17, 2025 at 3:57 AM
herpesadvocate.bsky.social
Wow, great news coming from Assembly Biosciences! They have dosed their first subject in their new genital herpes antiviral study! #CureHSV #SilentNoMore

www.clinicaltrialsarena.com/news/assembl...
First subject dosed in Assembly Biosciences’ study for genital herpes
Assembly Biosciences has dosed the first subject in the Phase Ia/b study’s Phase Ib portion, evaluating ABI-1179.
www.clinicaltrialsarena.com
July 4, 2025 at 2:58 AM
herpesadvocate.bsky.social
Herpes Cure Advocacy is excited to welcome Dr. David Leib to Advancing Science. Advancing Science is series of talks designed for a professional and scientific audience. Visit the link below for more details and how to join!

#Herpes #NeonatalHerpes #CureHSV
herpescureadvocacy.com/event/advanc...
Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections
Advancing Science features a series of scientific talks from the brightest minds in HSV. Herpes Cure Advocacy is excited to welcome Dr. David Leib to Advancing Science. Advancing Science is series …
herpescureadvocacy.com
July 2, 2025 at 2:04 AM
herpesadvocate.bsky.social
The @KECKSchool_USC is hosting Dr. Keith Jerome on 6/5 for their Cell Therapy Program Seminar Series. Dr. Jerome will discuss HSV latency, features that make HSV attractive for gene editing, and more! Visit the link for more details! #CureHSV

keck.usc.edu/calendar/eve...
USC/CHLA Cell Therapy Program Seminar Series: Gene Editing for Durable Control of Herpes Simplex Virus Infections
We are thrilled to announce that Dr. Keith R. Jerome will be joining our USC/CHLA Cell Therapy Program Seminar Series on June 5th! Join for an insightful seminar where Dr. Jerome will discuss: HSV lat...
keck.usc.edu
May 19, 2025 at 4:03 AM
herpesadvocate.bsky.social
New data from @ExcisionBio!!

#CureHSV #SilentNoMore #HerpesAdvocacy

www.globenewswire.com/news-release...
Excision BioTherapeutics Presents Data from HBV and HSV Programs at the ASGCT 2025 Annual Meeting
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of...
www.globenewswire.com
May 15, 2025 at 3:44 AM
herpesadvocate.bsky.social
What did you think of the Herpes Cure Pipeline? If you were unable to attend the live session, the recording is now added to our website! Check out the recording and the pipeline document! We'd love to hear your thoughts!

#CureHSV #SilentNoMore #Herpes

herpescureadvocacy.com/2025/04/22/h...
Herpes Cure Pipeline 4.0
The Herpes Cure Pipeline 4.0 is here! Herpes Cure Pipeline 4.0 Release Talk with Q&A The Herpes Cure Pipeline is a proprietary report produced by Herpes Cure Advocacy outlining active pre-clini…
herpescureadvocacy.com
May 10, 2025 at 5:16 AM
herpesadvocate.bsky.social
Who’s excited to learn about HSV Diagnostics?! We are! Later today, Dr Gillim from LabCorp will present Challenges and Limitations on HSV Lab Testing. See more info and how to register below!

#CureHSV #SilentNoMore #EndHerpes

herpescureadvocacy.com/event/hsv-di...
HSV Laboratory Testing:  Challenges and Limitations
Laura Gillim, Phd is Medical Science Liaison, Infectious Disease at Labcorp and a Discipline Director for Infectious Disease Immunology. Laura was previously a scientific director in the department…
herpescureadvocacy.com
April 22, 2025 at 3:40 PM
herpesadvocate.bsky.social
THIS is what happens when society claims herpes is benign. When proper education around herpes isn't available. This is what happens when there isn't proper treatment or diagnosis of herpes. WE CAN DO BETTER.

#CureHSV #SilentNoMore #HerpesAwareness

metro.co.uk/2025/03/10/t...
Toddler may lose his eye after being kissed by someone with herpes virus
‘It is not fair for such a tiny human to go through all that.'
metro.co.uk
March 14, 2025 at 1:34 AM
herpesadvocate.bsky.social
Have some time? We’ve been updating our advocates guide! We have new stakeholders to reach out to, new resources to share in your efforts! Use your voice!

#Advocate #Herpes #CureHSV #SilentNoMore

herpescureadvocacy.com/2021/10/16/n...
New HSV Advocates: A Starters Guide to Activism
Getting started with Herpes Advocacy Step 1: Get Informed GET INFORMED: Make sure you know the Herpes 101 facts so you can speak to them in your advocacy. Read the latest news. Sign up for Herpes C…
herpescureadvocacy.com
March 5, 2025 at 8:04 PM
herpesadvocate.bsky.social
Needing resources for your advocacy efforts? Check out our downloadable information packets! Send these to your state reps! Bring these to meetings! Spread awareness and educate others about herpes!

#Herpes #HerpesAwareness #CureHSV

herpescureadvocacy.com/%f0%9f%93%a2...
📢 Herpes Cure Advocacy Resources
Download our flyers and information packet to help spread awareness and push for a cure! These advocacy materials are designed to educate stakeholders, engage the public, and drive action toward be…
herpescureadvocacy.com
March 4, 2025 at 2:39 AM
herpesadvocate.bsky.social
Have you registered yet for our talk on immunocompromised patient and acyclovir resistance? Join us 3/19 for what is sure to be a great talk!

#Herpes #Immunocompromised #CureHSV #SilentNoMore

herpescureadvocacy.com/event/the-im...
The Immunocompromised Patient and Acyclovir-Resistance
Dr. Shafat-Fainguelernt is an internal medicine physician and infectious disease specialist from Israel. She graduated from Ben Gurion University Medical School and received further training at the…
herpescureadvocacy.com
March 3, 2025 at 1:26 AM
herpesadvocate.bsky.social
Don’t forget! In partnership with HVTN, we are hosting a talk on Encephalitis tomorrow! Visit the link for more details! #WorldEncephalitisDay #CureHSV #SilentNoMore #Herpes

herpescureadvocacy.com/event/world-...
World Encephalitis Day Talk
Genetic defects of brain immunity underlying childhood Herpes simples encephalitis In partnership with the HIV Vaccine Trials Network (HVTN), we are starting off the 2025 Advancing Science Series w…
herpescureadvocacy.com
February 26, 2025 at 2:48 AM
herpesadvocate.bsky.social
Great news coming from Assembly Biosciences! Very promising results from their ABI-1179 trial!

#Herpes #HerpesAwareness #SilentNoMore #CureHSV

investor.assemblybio.com/news-release...
investor.assemblybio.com
February 22, 2025 at 6:12 PM
herpesadvocate.bsky.social
🙌 Champions talk about health openly—let’s normalize the conversation!

No need to sit on the sidelines—advocate, educate, and support! 🏆💙 #NoStigmaSuperBowl #HerpesAwareness #MVPsTalkHealth #SilentNoMore #CureHSV
February 10, 2025 at 1:04 AM